Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Howie, Sacks & Henry
In this blog post, I explore some research into the long-term use of baby (talcum) powder and why Johnson & Johnson would prefer if you would focus on its pleasant smell...
Bennett Jones LLP
The government of Prince Edward Island released details about its retail and distribution model for recreational cannabis on Tuesday.
Aird & Berlis LLP
Finally, a Little Miss character to spark the imagination of budding young female engineers and scientists: Little Miss Inventor.
Minden Gross LLP
On November 21, 2017, the Canadian Government released a consultation paper that contains regulatory proposals for the implementation of legal recreational cannabis.
Howie, Sacks & Henry
Preventable medical errors kill about 30,000 Canadians every year. To put those eye-popping numbers into perspective, the former president and CEO of Toronto's University Health Network...
Miller Thomson LLP
The stated intention of this legislation is to strengthen transparency and increase patient trust in the health care system.
Aird & Berlis LLP
On January 12, 2018, the Canadian Securities Administrators announced that they were considering their disclosure-based regulatory approach for issuers with U.S. marijuana-related activities.
Bennett Jones LLP
As the July 2018 date of legalization approaches, Canadian provinces continue to announce their plans for the regulation, distribution and sale of recreational cannabis.
Miller Thomson LLP
Bill S-214 ("Bill") proposes a prohibition on testing cosmetics on animals and selling cosmetics manufactured using cosmetic animal testing.
Smart & Biggar/Fetherstonhaugh
Apotex was unsuccessful in three Health Canada court challenges.
Miller Thomson LLP
The LAT CAT is now out of the bag with the recent release of one of the Licence Appeal Tribunal's most comprehensive CAT decisions in A.R. v. Allstate (Tribunal File No. 16-003415, January 5, 2018).
Smart & Biggar/Fetherstonhaugh
Separately, in Ontario, on December 12, Bill 160, the Strengthening Quality and Accountability for Patients Act, 2017, received Royal Assent.
Smart & Biggar/Fetherstonhaugh
We reported on the six Federal Court and three FCA PMNOC Regulations decisions publicly released in 2017.
Torkin Manes LLP
In November 2017, Torkin Manes published an article that provided an overview of Health Canada's consultation paper, Proposed Approach to the Regulation of Cannabis, which sets out proposals regarding the regulation...
Smart & Biggar/Fetherstonhaugh
We provided an update on biosimilars: Health Canada's guidance, approvals and reviews of biosimilars to date, the effect of CETA amendments to biologics, pending patent litigation...
Smart & Biggar/Fetherstonhaugh
On February 2, the FCA allowed Apotex's appeal of a $61 million award disgorging Apotex's profits for its generic perindopril (COVERSYL).
Devry Smith Frank LLP
The Cannabis Act, once in force, prescribes a number of limitations regarding the personal cultivation and consumption of marijuana in Canada.
Osler, Hoskin & Harcourt LLP
Aurora issued a press release announcing that it had submitted a proposal to the board of directors of CanniMed to acquire all of the issued and outstanding common shares of CanniMed.
Dentons
The last year has been filled with sensational headlines relating to the spectacular growth and rise to prominence of Licensed Producers (as defined below) in response to the federal government's plan ...
Smart & Biggar/Fetherstonhaugh
Health Canada publishes final guidance documents on quality requirements for regulatory filings
Most Popular Recent Articles
Norton Rose Fulbright Canada LLP
Last week, we covered EY's recently released report (the Report) surveying the bourgeoning cannabis sector in Canada.
Borden Ladner Gervais LLP
Our annual thought leadership report is now available to download.
Minden Gross LLP
After the markets closed this past Friday, January 12, 2018, CanniMed Therapeutics Inc. ("CanniMed"), announced that it had commenced a lawsuit against Aurora Cannabis Inc.
Devry Smith Frank LLP
Over the last half of 2017 there was a flood of information on what was going to take effect in 2018 and how we are to prepare for it all, taking the form of articles and news segments ...
Norton Rose Fulbright Canada LLP
As the government prepares for legalization of recreational marijuana this summer, Canada's cannabis producers and distributors are bracing themselves for a period of consolidation leading up to and following legalization.
Osler, Hoskin & Harcourt LLP
Aurora issued a press release announcing that it had submitted a proposal to the board of directors of CanniMed to acquire all of the issued and outstanding common shares of CanniMed.
Howie, Sacks & Henry
Preventable medical errors kill about 30,000 Canadians every year. To put those eye-popping numbers into perspective, the former president and CEO of Toronto's University Health Network...
Langlois lawyers, LLP
In prevision of the legalization of cannabis, which will become effective on July 1, 2018, provinces had to provide the legal frame to be respected by individuals and companies.
Osler, Hoskin & Harcourt LLP
A groundbreaking shift in policy in 2017 set the stage for the legalization of cannabis for recreational use in Canada, which the Canadian government indicates will occur no later than July 1, 2018
Torkin Manes LLP
In November 2017, Torkin Manes published an article that provided an overview of Health Canada's consultation paper, Proposed Approach to the Regulation of Cannabis, which sets out proposals regarding the regulation...
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with